The World Health Organization (WHO) has called for the inclusion of Human Papillomavirus (HPV) vaccination in immunisation programmes, especially in developing countries, to curb the rising prevalence of cervical cancer. Speaking during a seminar in Abuja themed Enhancing HPV Vaccine Awareness and Uptake in Nigeria, Dr. Ugochukwu, a Public Health specialist and consultant for the Vaccine Uptake Project, emphasised the need to target girls aged nine to fourteen before they become sexually active. He explained that introducing vaccination for multiple age cohorts, particularly girls aged nine to eighteen, would result in faster and broader population immunity than vaccinating single cohorts.
Dr. Ugochukwu also highlighted the devastating impact of HPV-related diseases, noting that HPV types 16 and 18 are responsible for 70 percent of cervical cancers, while types 6 and 11 cause 90 percent of anogenital warts. He further explained that 85 percent of cervical Cancer cases occur in less-developed regions, with hundreds of thousands of women losing their lives to the disease each year. This highlights the urgency of introducing preventive measures. He added that three prophylactic vaccines: Bivalent, Quadrivalent, and Nonavalent are available and highly effective. However, these Vaccines are preventive, not curative, making early administration critical to their success.
Media’s role in addressing vaccine misconceptions.
Despite the WHO’s recommendation of a two-dose schedule for HPV vaccination, which has proven to be both effective and affordable, myths and misconceptions have hindered its acceptance in Nigeria. Dr. Ugochukwu highlighted the media’s critical role in dispelling Misinformation and educating the public about the vaccine. He urged journalists to use their platforms to address vaccine hesitancy and foster greater trust among the population. This could help tackle misinformation and build trust in the vaccine, leading to improved vaccination rates nationwide..
Addressing vaccine accessibility remains a significant challenge, particularly in rural and underserved areas where healthcare Infrastructure is limited. Many girls in these regions face barriers such as poor road networks, inadequate healthcare facilities, and cultural hesitancy toward vaccination. Targeted outreach programmes are essential to bridge this gap. Mobile clinics can deliver vaccines directly to these communities, while collaboration with local leaders can help build trust and address cultural concerns. By bringing vaccination services closer to the people and engaging trusted voices, these efforts can ensure no girl is left behind, promoting equitable health outcomes nationwide.
Government should lead the charge in expanding HPV vaccine availability.
Moreover, awareness campaigns must aim to clarify misconceptions about the HPV vaccine and highlight its benefits in preventing cervical cancer. Sharing real-life stories of vaccinated girls can show its impact, while endorsements from trusted community voices, such as religious leaders and healthcare professionals, can lend credibility. Accurate, straightforward information is essential to address misinformation and ease parents’ concerns. As noted by Dr. Ugochukwu, the media’s role in disseminating these messages is vital, as it can reach a wide audience and promote understanding. Through these efforts, public confidence in the vaccine can grow, encouraging broader acceptance and uptake across communities.
Furthermore, the government must prioritise making the HPV vaccine a permanent component of Nigeria’s immunisation schedule to tackle the rising cases of cervical cancer effectively. This requires a comprehensive approach, including securing adequate funding to procure vaccines, training Healthcare Providers to ensure proper administration, and addressing supply chain challenges to prevent shortages in both urban and rural areas. Establishing partnerships with international organisations and local stakeholders can enhance resource mobilisation and support vaccine delivery. A coordinated effort not only increases coverage but also strengthens Nigeria’s healthcare infrastructure, creating a model for managing future public health challenges and preventing other vaccine-preventable diseases.
Related Article: HPV vaccine rollout: a milestone for Nigeria
Altogether, Investing in HPV vaccination goes beyond disease prevention; it represents a long-term commitment to safeguarding the health and well-being of Nigeria’s young girls and women. Preventing cervical cancer reduces the emotional, physical, and financial burden on families while decreasing strain on the nation’s healthcare system. A sustained focus on raising awareness, expanding access, and ensuring equitable vaccine distribution can reshape the narrative around HPV-related diseases. This initiative has the potential to save countless lives and transform the health landscape. Nigeria can demonstrate its leadership in global disease prevention, securing a healthier future for its citizens by overcoming these challenges